Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Alzheimer's Disease

Free Subscription Articles published in Brain Retrieve available abstracts of 222 articles: HTML format

Single Articles

April 2024
1. 
   Correction to: Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer's dementia.
   Brain. 2024 Apr 10:awae103. doi: 10.1093.
   PubMed    
   
   
   
2. WANG YT, Therriault J, Servaes S, Tissot C, et al
   Sex-specific modulation of amyloid-beta on tau phosphorylation underlies faster tangle accumulation in females.
   Brain. 2024;147:1497-1510.
   PubMed     Abstract available
   
   
   
3. TANAKA H, Martinez-Valbuena I, Forrest SL, Couto B, et al
   Distinct involvement of the cranial and spinal nerves in progressive supranuclear palsy.
   Brain. 2024;147:1399-1411.
   PubMed     Abstract available
   
   
   
4. CORRIVEAU-LECAVALIER N, Barnard LR, Botha H, Graff-Radford J, et al
   Uncovering the distinct macro-scale anatomy of dysexecutive and behavioural degenerative diseases.
   Brain. 2024;147:1483-1496.
   PubMed     Abstract available
   
   
   March 2024
5. HUNG C, Fertan E, Livesey FJ, Klenerman D, et al
   APP antisense oligonucleotides reduce Abeta aggregation and rescue endolysosomal dysfunction in Alzheimer's disease.
   Brain. 2024 Mar 25:awae092. doi: 10.1093.
   PubMed     Abstract available
   
   
   
6. RODRIGUEZ-RODRIGUEZ P, Arroyo-Garcia LE, Tsagkogianni C, Li L, et al
   A cell autonomous regulator of neuronal excitability modulates tau in Alzheimer's disease vulnerable neurons.
   Brain. 2024 Mar 11:awae051. doi: 10.1093.
   PubMed     Abstract available
   
   
   
7. RODRIGUEZ-VIEITEZ E, Vannini P, Montal V, Graff C, et al
   Cortical microstructural imaging from diffusion MRI: towards sensitive biomarkers for clinical trials.
   Brain. 2024;147:746-748.
   PubMed    
   
   
   
8. DE MEYER S, Blujdea ER, Schaeverbeke J, Reinartz M, et al
   Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changes.
   Brain. 2024;147:936-948.
   PubMed     Abstract available
   
   
   February 2024
9. YANG HS, Yau WW, Carlyle BC, Trombetta BA, et al
   Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer's disease.
   Brain. 2024 Feb 5:awae034. doi: 10.1093.
   PubMed     Abstract available
   
   
   
10. AHMED H, Wang Y, Griffiths WJ, Levey AI, et al
    Brain cholesterol and Alzheimer's disease: challenges and opportunities in probe and drug development.
    Brain. 2024 Feb 1:awae028. doi: 10.1093.
    PubMed     Abstract available
    
    
    
11. ALBERT-GASCO H, Smith HL, Alvarez-Castelao B, Swinden D, et al
    Trazodone rescues dysregulated synaptic and mitochondrial nascent proteomes in prion neurodegeneration.
    Brain. 2024;147:649-664.
    PubMed     Abstract available
    
    
    January 2024
12. KUMAR M, Quittot N, Dujardin S, Schlaffner CN, et al
    Alzheimer proteopathic tau seeds are biochemically a forme fruste of mature paired helical filaments.
    Brain. 2024 Jan 18:awad378. doi: 10.1093.
    PubMed     Abstract available
    
    
    
13. KIIANITSA K, Lukes ME, Hayes BJ, Brutman J, et al
    TREM2 variants that cause early dementia and increase Alzheimer's disease risk affect gene splicing.
    Brain. 2024 Jan 16:awae014. doi: 10.1093.
    PubMed     Abstract available
    
    
    
14. HAN Y, Chen K, Zhang B, Yu H, et al
    Maf1 loss regulates spinogenesis and attenuates cognitive impairment in Alzheimer's disease.
    Brain. 2024 Jan 16:awae015. doi: 10.1093.
    PubMed     Abstract available
    
    
    
15. QIN C, Chen M, Dong MH, Yang S, et al
    Soluble TREM2 triggers microglial dysfunction in neuromyelitis optica spectrum disorders.
    Brain. 2024;147:163-176.
    PubMed     Abstract available
    
    
    December 2023
16. SAMANTA S, Akhter F, Roy A, Chen D, et al
    New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer's disease.
    Brain. 2023 Dec 26:awad432. doi: 10.1093.
    PubMed     Abstract available
    
    
    
17. SPOTORNO N, Strandberg O, Stomrud E, Janelidze S, et al
    Diffusion MRI tracks cortical microstructural changes during the early stages of Alzheimer's disease.
    Brain. 2023 Dec 21:awad428. doi: 10.1093.
    PubMed     Abstract available
    
    
    
18. STOUFFER KM, Grande X, Duezel E, Johansson M, et al
    Amidst an amygdala renaissance in Alzheimer's disease.
    Brain. 2023 Dec 18:awad411. doi: 10.1093.
    PubMed     Abstract available
    
    
    
19. YUYAMA K, Sun H, Fujii R, Hemmi I, et al
    Extracellular vesicle proteome unveils cathepsin B connection to Alzheimer's disease pathogenesis.
    Brain. 2023 Dec 10:awad361. doi: 10.1093.
    PubMed     Abstract available
    
    
    
20. TARUTANI A, Kametani F, Tahira M, Saito Y, et al
    Distinct tau folds initiate templated seeding and alter the post-translational modification profile.
    Brain. 2023;146:4988-4999.
    PubMed     Abstract available
    
    
    
21. GUBERT C, Hannan AJ
    Microbial manipulation of memories and minds.
    Brain. 2023;146:4791-4793.
    PubMed    
    
    
    November 2023
22. QUESNEL MJ, Labonte A, Picard C, Zetterberg H, et al
    Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brains.
    Brain. 2023 Nov 22:awad398. doi: 10.1093.
    PubMed     Abstract available
    
    
    
23. SILVA-RODRIGUEZ J, Labrador-Espinosa MA, Moscoso A, Scholl M, et al
    Characteristics of amnestic patients with hypometabolism patterns suggestive of Lewy body pathology.
    Brain. 2023;146:4520-4531.
    PubMed     Abstract available
    
    
    
24. HAMPEL H, Elhage A, Cho M, Apostolova LG, et al
    Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics.
    Brain. 2023;146:4414-4424.
    PubMed     Abstract available
    
    
    
25. RAMANAN VK, Gebre RK, Graff-Radford J, Hofrenning E, et al
    Genetic risk scores enhance the diagnostic value of plasma biomarkers of brain amyloidosis.
    Brain. 2023;146:4508-4519.
    PubMed     Abstract available
    
    
    October 2023
26. GRABRUCKER S, Marizzoni M, Silajdzic E, Lopizzo N, et al
    Microbiota from Alzheimer's patients induce deficits in cognition and hippocampal neurogenesis.
    Brain. 2023 Oct 18:awad303. doi: 10.1093.
    PubMed     Abstract available
    
    
    
27. TUNOLD JA, Tan MMX, Koga S, Geut H, et al
    Lysosomal polygenic risk is associated with the severity of neuropathology in Lewy body disease.
    Brain. 2023;146:4077-4087.
    PubMed     Abstract available
    
    
    
28. KEPP KP, Robakis NK, Hoilund-Carlsen PF, Sensi SL, et al
    The amyloid cascade hypothesis: an updated critical review.
    Brain. 2023;146:3969-3990.
    PubMed     Abstract available
    
    
    
29. DU F, Yu Q, Swerdlow RH, Waites CL, et al
    Glucocorticoid-driven mitochondrial damage stimulates Tau pathology.
    Brain. 2023;146:4378-4394.
    PubMed     Abstract available
    
    
    September 2023
30. COOMANS EM, van Westen D, Pichet Binette A, Strandberg O, et al
    Interactions between vascular burden and amyloid-beta pathology on trajectories of tau accumulation.
    Brain. 2023 Sep 18:awad317. doi: 10.1093.
    PubMed     Abstract available
    
    
    
31. HARDY J, Mummery C
    Reply: Lecanemab: turning point, or status quo? An ethics perspective.
    Brain. 2023;146:e73.
    PubMed    
    
    
    
32. BOCANCEA DI, Svenningsson AL, van Loenhoud AC, Groot C, et al
    Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis.
    Brain. 2023;146:3719-3734.
    PubMed     Abstract available
    
    
    
33. DALY T
    Lecanemab: turning point, or status quo? An ethics perspective.
    Brain. 2023;146:e71-e72.
    PubMed    
    
    
    
34. COOMANS EM, Tomassen J, Ossenkoppele R, Tijms BM, et al
    Genetically identical twin-pair difference models support the amyloid cascade hypothesis.
    Brain. 2023;146:3735-3746.
    PubMed     Abstract available
    
    
    August 2023
35. KERAMIDIS I, McAllister BB, Bourbonnais J, Wang F, et al
    Restoring neuronal chloride extrusion reverses cognitive decline linked to Alzheimer's disease mutations.
    Brain. 2023 Aug 8:awad250. doi: 10.1093.
    PubMed     Abstract available
    
    
    
36. JUNG Y, Damoiseaux JS
    The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer's disease.
    Brain. 2023 Aug 4:awad267. doi: 10.1093.
    PubMed     Abstract available
    
    
    
37. WUESTEFELD A, Pichet Binette A, Berron D, Spotorno N, et al
    Age-related and amyloid-beta-independent tau deposition and its downstream effects.
    Brain. 2023;146:3192-3205.
    PubMed     Abstract available
    
    
    
38. RAHAYEL S, Tremblay C, Vo A, Misic B, et al
    Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies.
    Brain. 2023;146:3301-3318.
    PubMed     Abstract available
    
    
    
39. MCMILLAN PJ, Benbow SJ, Uhrich R, Saxton A, et al
    Tau-RNA complexes inhibit microtubule polymerization and drive disease-relevant conformation change.
    Brain. 2023;146:3206-3220.
    PubMed     Abstract available
    
    
    July 2023
40. GARCIA AM, de Leon J, Tee BL, Blasi DE, et al
    Speech and language markers of neurodegeneration: a call for global equity.
    Brain. 2023 Jul 27:awad253. doi: 10.1093.
    PubMed     Abstract available
    
    
    
41. AKSMAN LM, Oxtoby NP, Scelsi MA, Wijeratne PA, et al
    A data-driven study of Alzheimer's disease related amyloid and tau pathology progression.
    Brain. 2023 Jul 11:awad232. doi: 10.1093.
    PubMed     Abstract available
    
    
    
42. YOUNG AL, Vogel JW, Robinson JL, McMillan CT, et al
    Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies.
    Brain. 2023;146:2975-2988.
    PubMed     Abstract available
    
    
    June 2023
43. 
    Correction to: Brain-derived tau: a novel blood-based biomarker for Alzheimer's disease-type neurodegeneration.
    Brain. 2023 Jun 27:awad208. doi: 10.1093.
    PubMed    
    
    
    
44. VAN DER ENDE EL, In 't Veld SGJG, Hanskamp I, van der Lee S, et al
    CSF proteomics in autosomal dominant Alzheimer's disease highlights parallels with sporadic disease.
    Brain. 2023 Jun 22:awad213. doi: 10.1093.
    PubMed     Abstract available
    
    
    
45. BANERJEE G, Collinge J, Fox NC, Lashley T, et al
    Clinical considerations in early-onset cerebral amyloid angiopathy.
    Brain. 2023 Jun 6:awad193. doi: 10.1093.
    PubMed     Abstract available
    
    
    
46. SCHOONHOVEN DN, Coomans EM, Millan AP, van Nifterick AM, et al
    Tau protein spreads through functionally connected neurons in Alzheimer's disease: a combined MEG/PET study.
    Brain. 2023 Jun 5:awad189. doi: 10.1093.
    PubMed     Abstract available
    
    
    
47. 
    Correction: The most valuable player or the tombstone: is tau the correct target to treat Alzheimer's disease?
    Brain. 2023 Jun 1:awad176. doi: 10.1093.
    PubMed    
    
    
    
48. EDWARDS HM, Wallace CE, Gardiner WD, Doherty BM, et al
    Sex-dependent effects of acute stress on amyloid-beta in male and female mice.
    Brain. 2023;146:2268-2274.
    PubMed     Abstract available
    
    
    
49. ROBINSON JL, Xie SX, Baer DR, Suh E, et al
    Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated.
    Brain. 2023;146:2557-2569.
    PubMed     Abstract available
    
    
    May 2023
50. ZHU M, Xiao B, Xue T, Qin S, et al
    Cdc42GAP deficiency contributes to the Alzheimer's disease phenotype.
    Brain. 2023 May 31:awad184. doi: 10.1093.
    PubMed     Abstract available
    
    
    
51. DAS V, Hajduch M
    Randomizing for Alzheimer's disease drug trials should consider the cancer history of participants.
    Brain. 2023 May 27:awad177. doi: 10.1093.
    PubMed    
    
    
    
52. HARDY J, Mummery C
    Reply: Unblinding in the lecanemab trial in Alzheimer's disease.
    Brain. 2023 May 23:awad201. doi: 10.1093.
    PubMed    
    
    
    
53. VAN GOOL WA
    Unblinding in the lecanemab trial in Alzheimer's disease.
    Brain. 2023 May 18:awad171. doi: 10.1093.
    PubMed    
    
    
    
54. KORETSKY MJ, Alvarado C, Makarious MB, Vitale D, et al
    Genetic risk factor clustering within and across neurodegenerative diseases.
    Brain. 2023 May 16:awad161. doi: 10.1093.
    PubMed     Abstract available
    
    
    
55. JIANG J, Johnson JCS, Requena-Komuro MC, Benhamou E, et al
    Comprehension of acoustically degraded speech in Alzheimer's disease and primary progressive aphasia.
    Brain. 2023 May 15:awad163. doi: 10.1093.
    PubMed     Abstract available
    
    
    
56. YOUNES K, Sha SJ
    The MVP or the tombstone: is tau the correct target to treat Alzheimer's disease?
    Brain. 2023 May 8:awad151. doi: 10.1093.
    PubMed    
    
    
    April 2023
57. GOSSYE H, Van Mossevelde S, Sieben A, Bjerke M, et al
    Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum.
    Brain. 2023;146:1624-1636.
    PubMed     Abstract available
    
    
    
58. PONNUSAMY M, Wang S, Yuksel M, Hansen MT, et al
    Loss of forebrain BIN1 attenuates hippocampal pathology and neuroinflammation in a tauopathy model.
    Brain. 2023;146:1561-1579.
    PubMed     Abstract available
    
    
    
59. NAM MH, Ko HY, Kim D, Lee S, et al
    Visualizing reactive astrocyte-neuron interaction in Alzheimer's disease using 11C-acetate and 18F-FDG.
    Brain. 2023 Apr 17:awad037. doi: 10.1093.
    PubMed     Abstract available
    
    
    
60. MATTSSON-CARLGREN N, Palmqvist S
    The emerging era of staging Alzheimer's disease pathology using plasma biomarkers.
    Brain. 2023 Apr 6:awad112. doi: 10.1093.
    PubMed    
    
    
    March 2023
61. 
    Correction to: Blood-brain barrier opening of the default mode network in Alzheimer's disease with magnetic resonance-guided focused ultrasound.
    Brain. 2023 Mar 22:awad082. doi: 10.1093.
    PubMed    
    
    
    
62. DONADIO V, Incensi A, Rizzo G, Westermark GT, et al
    Phosphorylated alpha-synuclein in skin Schwann cells: a new biomarker for multiple system atrophy.
    Brain. 2023;146:1065-1074.
    PubMed     Abstract available
    
    
    
63. GREVE HJ, Dunbar AL, Lombo CG, Ahmed C, et al
    The bidirectional lung brain-axis of amyloid-beta pathology: ozone dysregulates the peri-plaque microenvironment.
    Brain. 2023;146:991-1005.
    PubMed     Abstract available
    
    
    February 2023
64. HARDY J, Mummery C
    An anti-amyloid therapy works for Alzheimer's disease: why has it taken so long and what is next?
    Brain. 2023 Feb 17:awad049. doi: 10.1093.
    PubMed    
    
    
    
65. JACK CR, Wiste HJ, Algeciras-Schimnich A, Figdore DJ, et al
    Predicting amyloid PET and tau PET stages with plasma biomarkers.
    Brain. 2023 Feb 15:awad042. doi: 10.1093.
    PubMed     Abstract available
    
    
    
66. HUSAIN M
    Screening for Alzheimer's disease: plasma biomarkers and what else?
    Brain. 2023;146:407-408.
    PubMed    
    
    
    
67. FLORIAN H, Wang D, Arnold SE, Boada M, et al
    Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study.
    Brain. 2023 Feb 2:awad024. doi: 10.1093.
    PubMed     Abstract available
    
    
    
68. KOCH G, Martorana A
    Reply: Can transcranial magnetic stimulation rescue dopaminergic signalling in Alzheimer disease?
    Brain. 2023 Feb 2:awad020. doi: 10.1093.
    PubMed    
    
    
    
69. D'AMELIO M, Di Lazzaro V
    Can transcranial magnetic stimulation rescue dopaminergic signalling in Alzheimer disease?
    Brain. 2023 Feb 2:awad019. doi: 10.1093.
    PubMed    
    
    
    January 2023
70. MARUSZAK A, Silajdzic E, Lee H, Murphy T, et al
    Predicting progression to Alzheimer's disease with human hippocampal progenitors exposed to serum.
    Brain. 2023 Jan 27:awac472. doi: 10.1093.
    PubMed     Abstract available
    
    
    
71. MENG Y, Goubran M, Rabin JS, McSweeney M, et al
    Blood-brain barrier opening of the default mode network in Alzheimer's disease with magnetic resonance-guided focused ultrasound.
    Brain. 2023 Jan 25:awac459. doi: 10.1093.
    PubMed     Abstract available
    
    
    
72. PERNECZKY R, Jessen F, Grimmer T, Levin J, et al
    Anti-amyloid antibody therapies in Alzheimer's disease.
    Brain. 2023 Jan 19:awad005. doi: 10.1093.
    PubMed     Abstract available
    
    
    
73. JOHANSSON C, Thordardottir S, Laffita-Mesa J, Rodriguez-Vieitez E, et al
    Plasma biomarker profiles in autosomal dominant Alzheimer's disease.
    Brain. 2023 Jan 11:awac399. doi: 10.1093.
    PubMed     Abstract available
    
    
    
74. WHEELOCK MD, Strain JF, Mansfield P, Tu JC, et al
    Brain network decoupling with increased serum neurofilament and reduced cognitive function in Alzheimer's disease.
    Brain. 2023 Jan 10:awac498. doi: 10.1093.
    PubMed     Abstract available
    
    
    
75. VAN ARENDONK J, Neitzel J, Steketee RME, van Assema DME, et al
    Diabetes and hypertension are related to amyloid-beta burden in the population-based Rotterdam Study.
    Brain. 2023;146:337-348.
    PubMed     Abstract available
    
    
    
76. KATSUMI Y, Putcha D, Eckbo R, Wong B, et al
    Anterior dorsal attention network tau drives visual attention deficits in posterior cortical atrophy.
    Brain. 2023;146:295-306.
    PubMed     Abstract available
    
    
    
77. BLOMMER J, Pitcher T, Mustapic M, Eren E, et al
    Extracellular vesicle biomarkers for cognitive impairment in Parkinson's disease.
    Brain. 2023;146:195-208.
    PubMed     Abstract available
    
    
    December 2022
78. GONZALEZ-ORTIZ F, Turton M, Kac PR, Smirnov D, et al
    Brain-derived tau: a novel blood-based biomarker for Alzheimer's disease-type neurodegeneration.
    Brain. 2022 Dec 27:awac407. doi: 10.1093.
    PubMed     Abstract available
    
    
    
79. KOOP EA, Jacobs HIL
    Untangling white matter fibre changes in Alzheimer's disease and small vessel disease.
    Brain. 2022 Dec 26:awac493. doi: 10.1093.
    PubMed    
    
    
    
80. WISCH JK, Butt OH, Gordon BA, Schindler SE, et al
    Proteomic clusters underlie heterogeneity in preclinical Alzheimer's disease progression.
    Brain. 2022 Dec 21:awac484. doi: 10.1093.
    PubMed     Abstract available
    
    
    
81. PERANI D
    The impact of integrated brain molecular PET measures on DLB cognitive phenotype and clinical course.
    Brain. 2022;145:4157-4159.
    PubMed    
    
    
    November 2022
82. MOUSSAVI Z
    Repetitive TMS applied to the precuneus stabilizes cognitive status in Alzheimer's disease.
    Brain. 2022;145:3730-3732.
    PubMed    
    
    
    
83. OBERSTEIN TJ, Schmidt MA, Florvaag A, Haas AL, et al
    Amyloid-beta levels and cognitive trajectories in non-demented pTau181-positive subjects without amyloidopathy.
    Brain. 2022;145:4032-4041.
    PubMed     Abstract available
    
    
    
84. BETTHAUSER TJ, Bilgel M, Koscik RL, Jedynak BM, et al
    Multi-method investigation of factors influencing amyloid onset and impairment in three cohorts.
    Brain. 2022;145:4065-4079.
    PubMed     Abstract available
    
    
    
85. HUGHES TM, Craft S
    Cerebral insulin receptors: a nexus for vascular and metabolic contributions to Alzheimer's disease.
    Brain. 2022 Nov 19:awac433. doi: 10.1093.
    PubMed    
    
    
    October 2022
86. SEYEDSALEHI A, Warrier V, Bethlehem RAI, Perry BI, et al
    Educational attainment, structural brain reserve and Alzheimer's disease: a Mendelian randomization analysis.
    Brain. 2022 Oct 31. pii: 6780317. doi: 10.1093.
    PubMed     Abstract available
    
    
    
87. NEMY M, Dyrba M, Brosseron F, Buerger K, et al
    Cholinergic white matter pathways along the Alzheimer's disease continuum.
    Brain. 2022 Oct 26. pii: 6775152. doi: 10.1093.
    PubMed     Abstract available
    
    
    
88. KOCH G, Casula EP, Bonni S, Borghi I, et al
    Precuneus magnetic stimulation for Alzheimer's disease: a randomized, sham-controlled trial.
    Brain. 2022 Oct 25. pii: 6701823. doi: 10.1093.
    PubMed     Abstract available
    
    
    
89. LECLERC M, Bourassa P, Tremblay C, Caron V, et al
    Cerebrovascular insulin receptors are defective in Alzheimer's disease.
    Brain. 2022 Oct 25. pii: 6761474. doi: 10.1093.
    PubMed     Abstract available
    
    
    
90. LI X, Ospitalieri S, Robberechts T, Hofmann L, et al
    Seeding, maturation and propagation of amyloid beta-peptide aggregates in Alzheimer's disease.
    Brain. 2022;145:3558-3570.
    PubMed     Abstract available
    
    
    
91. SINGLETON EH, Fieldhouse JLP, van 't Hooft JJ, Scarioni M, et al
    Social cognition deficits and biometric signatures in the behavioural variant of Alzheimer's disease.
    Brain. 2022 Oct 21. pii: 6765142. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2022
92. SPOTORNO N, Strandberg O, Vis G, Stomrud E, et al
    Measures of cortical microstructure are linked to amyloid pathology in Alzheimer's disease.
    Brain. 2022 Sep 21. pii: 6710203. doi: 10.1093.
    PubMed     Abstract available
    
    
    
93. JANELIDZE S, Bali D, Ashton NJ, Barthelemy NR, et al
    Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease.
    Brain. 2022 Sep 10. pii: 6695388. doi: 10.1093.
    PubMed     Abstract available
    
    
    
94. GROOT C, Smith R, Stomrud E, Binette AP, et al
    Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals.
    Brain. 2022 Sep 9. pii: 6695020. doi: 10.1093.
    PubMed     Abstract available
    
    
    
95. BUCKLEY R
    Sex differences in Alzheimer's disease risk: are immune responses the key?
    Brain. 2022 Sep 2. pii: 6686583. doi: 10.1093.
    PubMed    
    
    
    August 2022
96. RABIN JS, Nichols E, La Joie R, Casaletto KB, et al
    Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline.
    Brain. 2022;145:2823-2833.
    PubMed     Abstract available
    
    
    
97. SNELLMAN A, Lantero-Rodriguez J, Emersic A, Vrillon A, et al
    N-terminal and mid-region tau fragments as fluid biomarkers in neurological diseases.
    Brain. 2022;145:2834-2848.
    PubMed     Abstract available
    
    
    
98. RIKU Y, Iwasaki Y, Ishigaki S, Akagi A, et al
    Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
    Brain. 2022;145:2769-2784.
    PubMed     Abstract available
    
    
    
99. SAPKOTA D, Florian C, Doherty BM, White KM, et al
    Aqp4 stop codon readthrough facilitates amyloid-beta clearance from the brain.
    Brain. 2022 Aug 24. pii: 6671408. doi: 10.1093.
    PubMed     Abstract available
    
    
    
100. INSEL PS, Young CB, Aisen PS, Johnson KA, et al
     Tau positron emission tomography in preclinical Alzheimer's disease.
     Brain. 2022 Aug 13. pii: 6665667. doi: 10.1093.
     PubMed     Abstract available
     
     
     
101. COURSE MM, Gudsnuk K, Keene CD, Bird TD, et al
     Aberrant splicing of PSEN2, but not PSEN1, in individuals with sporadic Alzheimer's disease.
     Brain. 2022 Aug 11. pii: 6660735. doi: 10.1093.
     PubMed     Abstract available
     
     
     
102. LUO J, Agboola F, Grant E, Morris JC, et al
     Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan.
     Brain. 2022 Aug 4. pii: 6655799. doi: 10.1093.
     PubMed     Abstract available
     
     
     July 2022
103. HUSAIN M
     Molecular pathology and biomarker of progression in Alzheimer's disease.
     Brain. 2022;145:2229-2230.
     PubMed    
     
     
     
104. GROOT C, Holstege H, Ossenkoppele R
     Do genetic factors contribute to sex-specific differences in resilience to amyloid pathology?
     Brain. 2022;145:2239-2241.
     PubMed    
     
     
     
105. CASALETTO KB, Nichols E, Aslanyan V, Simone SM, et al
     Sex-specific effects of microglial activation on Alzheimer's disease proteinopathy in older adults.
     Brain. 2022 Jul 23. pii: 6648895. doi: 10.1093.
     PubMed     Abstract available
     
     
     
106. LONG JM, Coble DW, Xiong C, Schindler SE, et al
     Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes.
     Brain. 2022 Jul 22. pii: 6648721. doi: 10.1093.
     PubMed     Abstract available
     
     
     
107. DEWENTER A, Jacob MA, Cai M, Gesierich B, et al
     Disentangling the effects of Alzheimer's and small vessel disease on white matter fibre tracts.
     Brain. 2022 Jul 21. pii: 6647593. doi: 10.1093.
     PubMed     Abstract available
     
     
     
108. BIESSELS GJ
     Alzheimer's disease, cerebrovascular disease and dementia: lump, split or integrate?
     Brain. 2022 Jul 15. pii: 6644842. doi: 10.1093.
     PubMed    
     
     
     
109. WANG Q, Huang X, Su Y, Yin G, et al
     Activation of Wnt/beta-catenin pathway mitigates blood-brain barrier dysfunction in Alzheimer's disease.
     Brain. 2022 Jul 5. pii: 6630034. doi: 10.1093.
     PubMed     Abstract available
     
     
     June 2022
110. GRAHAM NSN
     Progress towards predicting neurodegeneration and dementia after traumatic brain injury.
     Brain. 2022;145:1874-1876.
     PubMed    
     
     
     
111. JENKINS LM, Wang L, Rosen H, Weintraub S, et al
     A transdiagnostic review of neuroimaging studies of apathy and disinhibition in dementia.
     Brain. 2022;145:1886-1905.
     PubMed     Abstract available
     
     
     
112. MEHRARAM R, Peraza LR, Murphy NRE, Cromarty RA, et al
     Functional and structural brain network correlates of visual hallucinations in Lewy body dementia.
     Brain. 2022;145:2190-2205.
     PubMed     Abstract available
     
     
     
113. LEVEY AI, Qiu D, Zhao L, Hu WT, et al
     A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment.
     Brain. 2022;145:1924-1938.
     PubMed     Abstract available
     
     
     
114. TANNER JA, Iaccarino L, Edwards L, Asken BM, et al
     Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer's disease.
     Brain. 2022 Jun 28. pii: 6619120. doi: 10.1093.
     PubMed     Abstract available
     
     
     
115. KAIVOLA K, Shah Z, Chia R, Scholz SW, et al
     Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups.
     Brain. 2022;145:1757-1762.
     PubMed     Abstract available
     
     
     May 2022
116. TONIOLO S
     What plasma biomarkers tell us about hippocampal microstructural changes in Alzheimer's disease.
     Brain. 2022 May 25. pii: 6591892. doi: 10.1093.
     PubMed    
     
     
     
117. DUZEL E, Ziegler G, Berron D, Maass A, et al
     Amyloid pathology but not APOE epsilon4 status is permissive for tau-related hippocampal dysfunction.
     Brain. 2022;145:1473-1485.
     PubMed     Abstract available
     
     
     
118. KO H, Kim S, Kim K, Jung SH, et al
     Genome-wide association study of occupational attainment as a proxy for cognitive reserve.
     Brain. 2022;145:1436-1448.
     PubMed     Abstract available
     
     
     
119. MORRIS JC, Weiner M, Xiong C, Beckett L, et al
     Autosomal dominant and sporadic late onset Alzheimer disease share a common in vivo pathophysiology.
     Brain. 2022 May 17. pii: 6587090. doi: 10.1093.
     PubMed     Abstract available
     
     
     
120. MORRISON MS, Aparicio HJ, Blennow K, Zetterberg H, et al
     Antemortem plasma phosphorylated tau (181) predicts Alzheimer's disease neuropathology and regional tau at autopsy.
     Brain. 2022 May 13. pii: 6585495. doi: 10.1093.
     PubMed     Abstract available
     
     
     
121. 
     Correction to: Brain amyloid-beta oligomers in ageing and Alzheimer's disease.
     Brain. 2022 May 13. pii: 6585189. doi: 10.1093.
     PubMed    
     
     
     
122. EISSMAN JM, Dumitrescu L, Mahoney ER, Smith AN, et al
     Sex differences in the genetic architecture of cognitive resilience to Alzheimer's disease.
     Brain. 2022 May 13. pii: 6585174. doi: 10.1093.
     PubMed     Abstract available
     
     
     
123. ZHU WM, Neuhaus A, Beard DJ, Sutherland BA, et al
     Neurovascular coupling mechanisms in health and neurovascular uncoupling in Alzheimer's disease.
     Brain. 2022 May 13. pii: 6585171. doi: 10.1093.
     PubMed     Abstract available
     
     
     
124. VROMEN EM, de Boer SCM, Teunissen CE, Rozemuller A, et al
     Biomarker A+T-: is this Alzheimer's disease or not? A combined CSF and pathology study.
     Brain. 2022 May 2. pii: 6576655. doi: 10.1093.
     PubMed     Abstract available
     
     
     April 2022
125. BARKER MS, Gottesman RT, Manoochehri M, Chapman S, et al
     Proposed research criteria for prodromal behavioural variant frontotemporal dementia.
     Brain. 2022;145:1079-1097.
     PubMed     Abstract available
     
     
     
126. LEGAZ A, Abrevaya S, Dottori M, Gonzalez Campo C, et al
     Multimodal mechanisms of human socially reinforced learning across neurodegenerative diseases.
     Brain. 2022;145:1052-1068.
     PubMed     Abstract available
     
     
     
127. MESULAM MM, Coventry CA, Bigio EH, Sridhar J, et al
     Neuropathological fingerprints of survival, atrophy and language in primary progressive aphasia.
     Brain. 2022 Apr 20. pii: 6570516. doi: 10.1093.
     PubMed     Abstract available
     
     
     
128. SHAHID SS, Wen Q, Risacher SL, Farlow MR, et al
     Hippocampal-subfield microstructures and their relation to plasma biomarkers in Alzheimer's disease.
     Brain. 2022 Apr 12. pii: 6566798. doi: 10.1093.
     PubMed     Abstract available
     
     
     
129. OLIVEROS G, Wallace CH, Chaudry O, Liu Q, et al
     Repurposing ibudilast to mitigate Alzheimer's disease by targeting inflammation.
     Brain. 2022 Apr 12. pii: 6566790. doi: 10.1093.
     PubMed     Abstract available
     
     
     
130. STEVENSON-HOARE J, Heslegrave A, Leonenko G, Fathalla D, et al
     Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer's disease.
     Brain. 2022 Apr 6. pii: 6564132. doi: 10.1093.
     PubMed     Abstract available
     
     
     
131. PADHI S, Sarangi S, Nayak N, Pati A, et al
     OAS1 rs1131454 genetic variant is associated with Alzheimer's disease: an epidemiological analysis.
     Brain. 2022 Apr 6. pii: 6564066. doi: 10.1093.
     PubMed    
     
     
     March 2022
132. JEONG YY, Han S, Jia N, Zhang M, et al
     Broad activation of the Parkin pathway induces synaptic mitochondrial deficits in early tauopathy.
     Brain. 2022;145:305-323.
     PubMed     Abstract available
     
     
     
133. BENATAR M, Wuu J, McHutchison C, Postuma RB, et al
     Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.
     Brain. 2022;145:27-44.
     PubMed     Abstract available
     
     
     
134. HOSOKAWA M, Masuda-Suzukake M, Shitara H, Shimozawa A, et al
     Development of a novel tau propagation mouse model endogenously expressing 3 and 4 repeat tau isoforms.
     Brain. 2022;145:349-361.
     PubMed     Abstract available
     
     
     
135. GIACOBINI E, Cuello AC, Fisher A
     Reimagining cholinergic therapy for Alzheimer's disease.
     Brain. 2022 Mar 15. pii: 6548684. doi: 10.1093.
     PubMed     Abstract available
     
     
     
136. SHETTY AK
     Can rapamycin slow down memory decline in Alzheimer's disease with seizures?
     Brain. 2022 Mar 12. pii: 6547363. doi: 10.1093.
     PubMed    
     
     
     
137. LAM AD, Shafi MM
     Towards a coherent view of network hyperexcitability in Alzheimer's disease.
     Brain. 2022 Mar 8. pii: 6544859. doi: 10.1093.
     PubMed    
     
     
     
138. LIN CP, Frigerio I, Boon BDC, Zhou Z, et al
     Structural (dys)connectivity associates with cholinergic cell density in Alzheimer's disease.
     Brain. 2022 Mar 8. pii: 6543231. doi: 10.1093.
     PubMed     Abstract available
     
     
     
139. GABRIELLI M, Prada I, Joshi P, Falcicchia C, et al
     Microglial large extracellular vesicles propagate early synaptic dysfunction in Alzheimer's disease.
     Brain. 2022 Mar 3. pii: 6541881. doi: 10.1093.
     PubMed     Abstract available
     
     
     February 2022
140. BEAMAN EE, Bonde AN, Ulv Larsen SM, Ozenne B, et al
     Blood-brain barrier permeable beta-blockers linked to lower risk of Alzheimer's disease in hypertension.
     Brain. 2022 Feb 23. pii: 6535129. doi: 10.1093.
     PubMed     Abstract available
     
     
     
141. PERIS L, Parato J, Qu X, Soleilhac JM, et al
     Tubulin tyrosination regulates synaptic function and is disrupted in Alzheimer's disease.
     Brain. 2022 Feb 11. pii: 6527175. doi: 10.1093.
     PubMed     Abstract available
     
     
     January 2022
142. KARANTH SD, Katsumata Y, Nelson PT, Fardo DW, et al
     Cancer diagnosis is associated with a lower burden of dementia and less Alzheimer's-type neuropathology.
     Brain. 2022 Jan 30. pii: 6517521. doi: 10.1093.
     PubMed     Abstract available
     
     
     
143. WIESMAN AI, Murman DL, Losh RA, Schantell M, et al
     Spatially resolved neural slowing predicts impairment and amyloid burden in Alzheimer's disease.
     Brain. 2022 Jan 28. pii: 6516524. doi: 10.1093.
     PubMed     Abstract available
     
     
     
144. MARTINO ADAMI PV, Orellana A, Garcia P, Kleineidam L, et al
     Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer's type.
     Brain. 2022 Jan 28. pii: 6516341. doi: 10.1093.
     PubMed     Abstract available
     
     
     
145. STERN AM, Liu L, Jin S, Liu W, et al
     A calcium-sensitive antibody isolates soluble amyloid-beta aggregates and fibrils from Alzheimer's disease brain.
     Brain. 2022 Jan 27. pii: 6516009. doi: 10.1093.
     PubMed     Abstract available
     
     
     
146. ALI M, Falkenhain K, Njiru BN, Murtaza-Ali M, et al
     VEGF signalling causes stalls in brain capillaries and reduces cerebral blood flow in Alzheimer's mice.
     Brain. 2022 Jan 20. pii: 6512043. doi: 10.1093.
     PubMed     Abstract available
     
     
     
147. BRIDEL C, Somers C, Sieben A, Rozemuller A, et al
     Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers.
     Brain. 2022 Jan 13. pii: 6506576. doi: 10.1093.
     PubMed     Abstract available
     
     
     
148. COOMANS EM, Tomassen J, Ossenkoppele R, Golla SSV, et al
     Genetically identical twins show comparable tau PET load and spatial distribution.
     Brain. 2022 Jan 12. pii: 6504924. doi: 10.1093.
     PubMed     Abstract available
     
     
     December 2021
149. LEE Y, Miller MR, Fernandez MA, Berg EL, et al
     Early lysosome defects precede neurodegeneration with amyloid-beta and tau aggregation in NHE6-null rat brain.
     Brain. 2021 Dec 20. pii: 6470622. doi: 10.1093.
     PubMed     Abstract available
     
     
     
150. RANASINGHE KG, Kudo K, Hinkley L, Beagle A, et al
     Neuronal synchrony abnormalities associated with subclinical epileptiform activity in early onset Alzheimer's disease.
     Brain. 2021 Dec 17. pii: 6469013. doi: 10.1093.
     PubMed     Abstract available
     
     
     
151. XHIMA K, Markham-Coultes K, Kofoed RH, Saragovi HU, et al
     Ultrasound delivery of a TrkA agonist confers neuroprotection to Alzheimer-associated pathologies.
     Brain. 2021 Dec 17. pii: 6469023. doi: 10.1093.
     PubMed     Abstract available
     
     
     
152. TSAI HH, Chen YF, Yen RF, Lo YL, et al
     Plasma soluble TREM2 is associated with white matter lesions independent of amyloid and tau.
     Brain. 2021;144:3371-3380.
     PubMed     Abstract available
     
     
     
153. PASCOAL TA, Benedet AL, Tudorascu DL, Therriault J, et al
     Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.
     Brain. 2021;144:3517-3528.
     PubMed     Abstract available
     
     
     
154. ABRAHAMSON EE, Kofler JK, Becker CR, Price JC, et al
     11C-PiB PET can underestimate brain amyloid-beta burden when cotton wool plaques are numerous.
     Brain. 2021 Dec 16. pii: 6464340. doi: 10.1093.
     PubMed     Abstract available
     
     
     November 2021
155. VERDI S, Marquand AF, Schott JM, Cole JH, et al
     Beyond the average patient: how neuroimaging models can address heterogeneity in dementia.
     Brain. 2021;144:2946-2953.
     PubMed     Abstract available
     
     
     October 2021
156. ZHANG Y, Zhang Y, Aman Y, Ng CT, et al
     Amyloid-beta toxicity modulates tau phosphorylation through the PAX6 signalling pathway.
     Brain. 2021;144:2759-2770.
     PubMed     Abstract available
     
     
     
157. LUCEY BP, Wisch J, Boerwinkle AH, Landsness EC, et al
     Sleep and longitudinal cognitive performance in preclinical and early symptomatic Alzheimer's disease.
     Brain. 2021 Oct 20. pii: 6401973. doi: 10.1093.
     PubMed     Abstract available
     
     
     
158. LEVY JP, Bezgin G, Savard M, Pascoal TA, et al
     18F-MK-6240 tau-PET in genetic frontotemporal dementia.
     Brain. 2021 Oct 19. pii: 6402002. doi: 10.1093.
     PubMed     Abstract available
     
     
     
159. MAGUSALI N, Graham AC, Piers TM, Panichnantakul P, et al
     A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene.
     Brain. 2021 Oct 7. pii: 6382473. doi: 10.1093.
     PubMed     Abstract available
     
     
     
160. KHAN AF, Adewale Q, Baumeister TR, Carbonell F, et al
     Personalized brain models identify neurotransmitter receptor changes in Alzheimer's disease.
     Brain. 2021 Oct 4. pii: 6380944. doi: 10.1093.
     PubMed     Abstract available
     
     
     
161. SCHUMACHER J, Ray NJ, Hamilton CA, Donaghy PC, et al
     Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer's disease.
     Brain. 2021 Oct 4. pii: 6380941. doi: 10.1093.
     PubMed     Abstract available
     
     
     September 2021
162. 
     Erratum to: Cardiovascular brain impulses in Alzheimer's disease.
     Brain. 2021 Sep 22. pii: 6373794. doi: 10.1093.
     PubMed    
     
     
     
163. STOTHART G, Smith LJ, Milton A, Coulthard E, et al
     A passive and objective measure of recognition memory in Alzheimer's disease using Fastball memory assessment.
     Brain. 2021 Sep 20. pii: 6372384. doi: 10.1093.
     PubMed     Abstract available
     
     
     August 2021
164. KHAN AR, Ottoy J, Goubran M
     Towards a comprehensive 3D mapping of tau progression in early Alzheimer's disease.
     Brain. 2021 Aug 23. pii: 6356553. doi: 10.1093.
     PubMed    
     
     
     
165. DAVILA-BOUZIGUET E, Casoliba-Melich A, Targa-Fabra G, Galera-Lopez L, et al
     Functional protection in J20/VLW mice: a model of non-demented with Alzheimer's disease neuropathology.
     Brain. 2021 Aug 23. pii: 6356505. doi: 10.1093.
     PubMed     Abstract available
     
     
     
166. BOYLE PA, Wang T, Yu L, Wilson RS, et al
     To what degree is late life cognitive decline driven by age-related neuropathologies?
     Brain. 2021;144:2166-2175.
     PubMed     Abstract available
     
     
     
167. HOLLAND N, Malpetti M, Rittman T, Mak EE, et al
     Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study.
     Brain. 2021 Aug 16. pii: 6353021. doi: 10.1093.
     PubMed     Abstract available
     
     
     
168. STROM A, Iaccarino L, Edwards L, Lesman-Segev OH, et al
     Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.
     Brain. 2021 Aug 9. pii: 6346980. doi: 10.1093.
     PubMed     Abstract available
     
     
     July 2021
169. PAUMIER A, Boisseau S, Jacquier-Sarlin M, Pernet-Gallay K, et al
     Astrocyte-neuron interplay is critical for Alzheimer's disease pathogenesis and is rescued by TRPA1 channel blockade.
     Brain. 2021 Jul 24. pii: 6327685. doi: 10.1093.
     PubMed     Abstract available
     
     
     
170. GOURMAUD S, Stewart DA, Irwin DJ, Roberts N, et al
     The role of mTORC1 activation in seizure-induced exacerbation of Alzheimer's disease.
     Brain. 2021 Jul 15. pii: 6321945. doi: 10.1093.
     PubMed     Abstract available
     
     
     
171. BERRON D, van Westen D, Ossenkoppele R, Strandberg O, et al
     Corrigendum to: Medial temporal lobe connectivity and its associations with cognition in early Alzheimer's disease.
     Brain. 2021 Jul 14. pii: 6321152. doi: 10.1093.
     PubMed    
     
     
     
172. PEREIRA JB, Janelidze S, Smith R, Mattsson-Carlgren N, et al
     Plasma GFAP is an early marker of amyloid-beta but not tau pathology in Alzheimer's disease.
     Brain. 2021 Jul 14. pii: 6321226. doi: 10.1093.
     PubMed     Abstract available
     
     
     
173. BAILES SM, Lewis LD
     Distinct cardiac-locked brain pulsations in Alzheimer's disease.
     Brain. 2021 Jul 9. pii: 6318392. doi: 10.1093.
     PubMed    
     
     
     
174. HORIE K, Barthelemy NR, Sato C, Bateman RJ, et al
     Corrigendum to: CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease.
     Brain. 2021 Jul 3. pii: 6313379. doi: 10.1093.
     PubMed    
     
     
     June 2021
175. RIES M, Watts H, Mota BC, Lopez MY, et al
     Annexin A1 restores cerebrovascular integrity concomitant with reduced amyloid-beta and tau pathology.
     Brain. 2021;144:1526-1541.
     PubMed     Abstract available
     
     
     
176. MATTHEWS DC, Mao X, Dowd K, Tsakanikas D, et al
     Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's disease.
     Brain. 2021 Jun 18. pii: 6305835. doi: 10.1093.
     PubMed     Abstract available
     
     
     
177. PATEL AG, Nehete PN, Krivoshik SR, Pei X, et al
     Innate immunity stimulation via CpG oligodeoxynucleotides ameliorates Alzheimer's disease pathology in aged squirrel monkeys.
     Brain. 2021 Jun 15. pii: 6297373. doi: 10.1093.
     PubMed     Abstract available
     
     
     
178. SCHUMACHER J, Gunter JL, Przybelski SA, Jones DT, et al
     Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks.
     Brain. 2021 Jun 11. pii: 6296589. doi: 10.1093.
     PubMed     Abstract available
     
     
     May 2021
179. 
     Erratum to: The development and convergence of co-pathologies in Alzheimer's disease.
     Brain. 2021 May 23. pii: 6282423. doi: 10.1093.
     PubMed    
     
     
     
180. DEHGHANI N, Bras J, Guerreiro R
     Erratum to: How understudied populations have contributed to our understanding of Alzheimer's disease genetics.
     Brain. 2021 May 20. pii: 6279241. doi: 10.1093.
     PubMed    
     
     
     April 2021
181. O'CONNOR A, Pannee J, Poole T, Arber C, et al
     Plasma amyloid-beta ratios in autosomal dominant Alzheimer's disease: the influence of genotype.
     Brain. 2021 Apr 23. pii: 6248083. doi: 10.1093.
     PubMed     Abstract available
     
     
     
182. DEHGHANI N, Bras J, Guerreiro R
     How understudied populations have contributed to our understanding of Alzheimer's disease genetics.
     Brain. 2021 Apr 23. pii: 6247156. doi: 10.1093.
     PubMed     Abstract available
     
     
     
183. YAO Y, Kang SS, Xia Y, Wang ZH, et al
     A delta-secretase-truncated APP fragment activates CEBPB, mediating Alzheimer's disease pathologies.
     Brain. 2021 Apr 20. pii: 6242262. doi: 10.1093.
     PubMed     Abstract available
     
     
     
184. 
     Erratum to: Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
     Brain. 2021 Apr 20. pii: 6238673. doi: 10.1093.
     PubMed    
     
     
     
185. OZAWA S, Hori Y, Shimizu Y, Taniguchi A, et al
     Photo-oxygenation by a biocompatible catalyst reduces amyloid-beta levels in Alzheimer's disease mice.
     Brain. 2021 Apr 14. pii: 6224831. doi: 10.1093.
     PubMed     Abstract available
     
     
     
186. TOME SO, Thal DR
     Co-pathologies in Alzheimer's disease: just multiple pathologies or partners in crime?
     Brain. 2021;144:706-708.
     PubMed    
     
     
     
187. 
     Corrigendum to: Monitoring the progression of Alzheimer's disease with tau-PET.
     Brain. 2021 Apr 6. pii: 6213355. doi: 10.1093.
     PubMed    
     
     
     March 2021
188. RAJNA Z, Mattila H, Huotari N, Tuovinen T, et al
     Cardiovascular brain impulses in Alzheimer's disease.
     Brain. 2021 Mar 31. pii: 6206368. doi: 10.1093.
     PubMed     Abstract available
     
     
     
189. YAP SY, Frias B, Wren MC, Scholl M, et al
     Discriminatory ability of next-generation tau PET tracers for Alzheimer's disease.
     Brain. 2021 Mar 20. pii: 6179104. doi: 10.1093.
     PubMed     Abstract available
     
     
     
190. EWERS M, Luan Y, Frontzkowski L, Neitzel J, et al
     Segregation of functional networks is associated with cognitive resilience in Alzheimer's disease.
     Brain. 2021 Mar 16. pii: 6174116. doi: 10.1093.
     PubMed     Abstract available
     
     
     
191. ASBY D, Boche D, Allan S, Love S, et al
     Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer's disease.
     Brain. 2021 Mar 16. pii: 6173392. doi: 10.1093.
     PubMed     Abstract available
     
     
     
192. SPINA S, La Joie R, Petersen C, Nolan AL, et al
     Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease.
     Brain. 2021 Mar 9. pii: 6164966. doi: 10.1093.
     PubMed     Abstract available
     
     
     
193. HUSAIN M
     Blood tests to screen for Alzheimer's disease.
     Brain. 2021;144:355-356.
     PubMed    
     
     
     
194. KIM JH, Afridi R, Han J, Jung HG, et al
     Gamma subunit of complement component 8 is a neuroinflammation inhibitor.
     Brain. 2021;144:528-552.
     PubMed     Abstract available
     
     
     February 2021
195. JAGUST W
     Integrating events in the disintegration of Alzheimer's disease.
     Brain. 2021;144:11-14.
     PubMed    
     
     
     
196. TIJMS BM, Teunissen CE
     Concatenating plasma p-tau to Alzheimer's disease.
     Brain. 2021;144:14-17.
     PubMed    
     
     
     January 2021
197. KESHAVAN A, Pannee J, Karikari TK, Rodriguez JL, et al
     Population-based blood screening for preclinical Alzheimer's disease in a British birth cohort at age 70.
     Brain. 2021 Jan 22. pii: 6105867. doi: 10.1093.
     PubMed     Abstract available
     
     
     
198. 
     Erratum to: Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons.
     Brain. 2021 Jan 12. pii: 6091150. doi: 10.1093.
     PubMed    
     
     
     December 2020
199. JOHNSON JCS, Marshall CR, Weil RS, Bamiou DE, et al
     Hearing and dementia: from ears to brain.
     Brain. 2020 Dec 22. pii: 6044086. doi: 10.1093.
     PubMed     Abstract available
     
     
     
200. MONTERO-CRESPO M, Dominguez-Alvaro M, Alonso-Nanclares L, DeFelipe J, et al
     Three-dimensional analysis of synaptic organization in the hippocampal CA1 field in Alzheimer's disease.
     Brain. 2020 Dec 16. pii: 6038920. doi: 10.1093.
     PubMed     Abstract available
     
     
     
201. HORIE K, Barthelemy NR, Sato C, Bateman RJ, et al
     CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease.
     Brain. 2020 Dec 7. pii: 6024973. doi: 10.1093.
     PubMed     Abstract available
     
     
     
202. TEUNISSEN CE, Thijssen EH, Verberk IMW
     Plasma p-tau217: from 'new kid' to most promising candidate for Alzheimer's disease blood test.
     Brain. 2020;143:3170-3172.
     PubMed    
     
     
     
203. PEREIRA JB, Janelidze S, Ossenkoppele R, Kvartsberg H, et al
     Untangling the association of amyloid-beta and tau with synaptic and axonal loss in Alzheimer's disease.
     Brain. 2020 Dec 5. pii: 6024803. doi: 10.1093.
     PubMed     Abstract available
     
     
     
204. TIJMS BM, Gobom J, Reus L, Jansen I, et al
     Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics.
     Brain. 2020;143:3776-3792.
     PubMed     Abstract available
     
     
     
205. SMITH R, Strandberg O, Mattsson-Carlgren N, Leuzy A, et al
     The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
     Brain. 2020;143:3805-3815.
     PubMed     Abstract available
     
     
     
206. FLORES-AGUILAR L, Iulita MF, Kovecses O, Torres MD, et al
     Evolution of neuroinflammation across the lifespan of individuals with Down syndrome.
     Brain. 2020;143:3653-3671.
     PubMed     Abstract available
     
     
     November 2020
207. MOSCOSO A, Grothe MJ, Ashton NJ, Karikari TK, et al
     Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
     Brain. 2020 Nov 30. pii: 6012955. doi: 10.1093.
     PubMed     Abstract available
     
     
     
208. BRIER MR, Day GS
     Serum neurofilament light chain uncovers neurodegeneration early in the course of Alzheimer's disease.
     Brain. 2020 Nov 30. pii: 6012788. doi: 10.1093.
     PubMed    
     
     
     
209. SUR C, Kost J, Scott D, Adamczuk K, et al
     BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain.
     Brain. 2020 Nov 30. pii: 6012787. doi: 10.1093.
     PubMed     Abstract available
     
     
     
210. RUAN Z, Pathak D, Venkatesan Kalavai S, Yoshii-Kitahara A, et al
     Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons.
     Brain. 2020 Nov 27. pii: 6007752. doi: 10.1093.
     PubMed     Abstract available
     
     
     
211. BENEDET AL, Leuzy A, Pascoal TA, Ashton NJ, et al
     Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
     Brain. 2020 Nov 19. pii: 5990278. doi: 10.1093.
     PubMed     Abstract available
     
     
     
212. JIA L, Li F, Wei C, Zhu M, et al
     Prediction of Alzheimer's disease using multi-variants from a Chinese genome-wide association study.
     Brain. 2020 Nov 14. pii: 5981992. doi: 10.1093.
     PubMed     Abstract available
     
     
     
213. LIU KY, Reeves S, McAleese KE, Attems J, et al
     Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer's disease.
     Brain. 2020 Nov 14. pii: 5981742. doi: 10.1093.
     PubMed     Abstract available
     
     
     
214. JI X, Liu G
     rs34331204 regulates TSPAN13 expression and contributes to Alzheimer's disease with sex differences.
     Brain. 2020 Nov 11. pii: 5974904. doi: 10.1093.
     PubMed    
     
     
     
215. DUMITRESCU L, Hohman TJ
     Reply: rs34331204 regulates TSPAN13 expression and contributes to Alzheimer's disease with sex differences.
     Brain. 2020 Nov 11. pii: 5974883. doi: 10.1093.
     PubMed    
     
     
     
216. JOSEPHS KA, Martin PR, Weigand SD, Tosakulwong N, et al
     Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy.
     Brain. 2020 Nov 5. pii: 5956321. doi: 10.1093.
     PubMed     Abstract available
     
     
     
217. SOLEIMANI-MEIGOONI DN, Iaccarino L, La Joie R, Baker S, et al
     18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
     Brain. 2020 Nov 3. pii: 5952719. doi: 10.1093.
     PubMed     Abstract available
     
     
     October 2020
218. MATTSSON-CARLGREN N, Janelidze S, Palmqvist S, Cullen N, et al
     Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease.
     Brain. 2020 Oct 17. pii: 5929275. doi: 10.1093.
     PubMed     Abstract available
     
     
     September 2020
219. HARDY CJD, Yong KXX, Goll JC, Crutch SJ, et al
     Impairments of auditory scene analysis in posterior cortical atrophy.
     Brain. 2020 Sep 1. pii: 5900355. doi: 10.1093.
     PubMed     Abstract available
     
     
     July 2020
220. PASCOAL TA, Therriault J, Benedet AL, Savard M, et al
     18F-MK-6240 PET for early and late detection of neurofibrillary tangles.
     Brain. 2020 Jul 16. pii: 5872095. doi: 10.1093.
     PubMed     Abstract available
     
     
     June 2020
221. PRZYBYLA M, van Eersel J, van Hummel A, van der Hoven J, et al
     Onset of hippocampal network aberration and memory deficits in P301S tau mice are associated with an early gene signature.
     Brain. 2020;143:1889-1904.
     PubMed     Abstract available
     
     
     January 2020
222. ROBINSON JL, Richardson H, Xie SX, Suh E, et al
     The development and convergence of co-pathologies in Alzheimer's disease.
     Brain. 2020 Jan 15. pii: 6101614. doi: 10.1093.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.